Lonza Group Ag Total Assets 2012-2024 | LZAGY
Lonza Group Ag total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Lonza Group Ag total assets for the quarter ending December 31, 2024 were $22.415B, a 29.27% increase year-over-year.
- Lonza Group Ag total assets for 2024 were $22.415B, a 19.44% increase from 2023.
- Lonza Group Ag total assets for 2023 were $18.767B, a 3.19% increase from 2022.
- Lonza Group Ag total assets for 2022 were $18.187B, a 1% increase from 2021.
| Lonza Group Ag Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $22,415 |
| 2023 | $18,767 |
| 2022 | $18,187 |
| 2021 | $18,008 |
| 2020 | $15,390 |
| 2019 | $13,931 |
| 2017 | $14,015 |
| 2016 | $6,932 |
| 2015 | $6,502 |
| 2014 | $7,048 |
| 2013 | $7,061 |
| 2012 | $7,576 |
| 2011 | $7,949 |
| Lonza Group Ag Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $22,415 |
| 2023-12-31 | $18,767 |
| 2023-06-30 | $19,658 |
| 2022-12-31 | $18,187 |
| 2022-06-30 | $17,339 |
| 2021-12-31 | $18,008 |
| 2021-06-30 | $16,642 |
| 2020-12-31 | $15,390 |
| 2020-06-30 | $14,473 |
| 2019-12-31 | $13,931 |
| 2019-06-30 | $13,462 |
| 2018-12-31 | $14,228 |
| 2018-06-30 | $14,215 |
| 2017-12-31 | $14,015 |
| 2017-06-30 | $9,740 |
| 2016-12-31 | $6,932 |
| 2016-06-30 | $6,485 |
| 2015-12-31 | $6,502 |
| 2015-06-30 | $6,424 |
| 2014-12-31 | $7,048 |
| 2014-06-30 | $7,427 |
| 2013-12-31 | $7,061 |
| 2013-06-30 | $7,431 |
| 2012-12-31 | $7,576 |
| 2012-06-30 | $7,502 |
| 2011-12-31 | $7,949 |
| 2011-06-30 | $5,065 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $50.094B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.206B | 27.56 |
| Boston Scientific (BSX) | United States | $152.664B | 38.22 |
| Stryker (SYK) | United States | $149.191B | 31.19 |
| EssilorLuxottica (ESLOY) | France | $131.913B | 0.00 |
| Medtronic (MDT) | Ireland | $115.147B | 16.32 |
| Haleon (HLN) | United Kingdom | $43.531B | 24.85 |
| ResMed (RMD) | United States | $37.280B | 28.00 |
| GE HealthCare Technologies (GEHC) | United States | $34.547B | 16.40 |
| Agilent Technologies (A) | United States | $32.221B | 21.01 |
| Terumo (TRUMY) | Japan | $24.355B | 31.64 |
| Koninklijke Philips (PHG) | Netherlands | $23.476B | 16.47 |
| Insulet (PODD) | United States | $20.287B | 79.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.641B | 11.97 |
| Baxter (BAX) | United States | $14.559B | 10.87 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.951B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.729B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.148B | 12.99 |
| Perrigo (PRGO) | Ireland | $3.724B | 9.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.715B | 16.59 |
| Haemonetics (HAE) | United States | $3.575B | 16.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.342B | 27.77 |
| ICU Medical (ICUI) | United States | $3.072B | 22.66 |
| LeMaitre Vascular (LMAT) | United States | $1.867B | 41.72 |
| QuidelOrtho (QDEL) | United States | $1.864B | 12.82 |
| AtriCure (ATRC) | United States | $1.504B | 0.00 |
| Acuren (TIC) | United States | $1.431B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.238B | 15.82 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Green Thumb Industries (GTBIF) | United States | $1.212B | 27.26 |
| Neogen (NEOG) | United States | $1.068B | 13.67 |
| BioLife Solutions (BLFS) | United States | $1.006B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.788B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Tilray Brands (TLRY) | Canada | $0.607B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.571B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Surmodics (SRDX) | United States | $0.446B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.331B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.321B | 11.82 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.300B | 0.00 |
| Quanterix (QTRX) | United States | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.30 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.75 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.202B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.152B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.16 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.87 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.76 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 49.29 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |